Avid Bioservices, Inc. (CDMO): Price and Financial Metrics

CDMO POWR Grades

• CDMO scores best on the Sentiment dimension, with a Sentiment rank ahead of 38.96% of US stocks.
• The strongest trend for CDMO is in Stability, which has been heading down over the past 177 days.
• CDMO ranks lowest in Growth; there it ranks in the 3rd percentile.

CDMO Stock Summary

• The price/operating cash flow metric for AVID BIOSERVICES INC is higher than 95.51% of stocks in our set with a positive cash flow.
• Of note is the ratio of AVID BIOSERVICES INC's sales and general administrative expense to its total operating expenses; 86.89% of US stocks have a lower such ratio.
• For CDMO, its debt to operating expenses ratio is greater than that reported by 88.92% of US equities we're observing.
• Stocks with similar financial metrics, market capitalization, and price volatility to AVID BIOSERVICES INC are CBZ, TRC, TIRX, SXTC, and JUPW.
• CDMO's SEC filings can be seen here. And to visit AVID BIOSERVICES INC's official web site, go to avidbio.com.

CDMO Valuation Summary

• In comparison to the median Healthcare stock, CDMO's price/sales ratio is 305% higher, now standing at 8.1.
• Over the past 243 months, CDMO's price/earnings ratio has gone up 14.

Below are key valuation metrics over time for CDMO.

CDMO Growth Metrics

The year over year revenue growth rate now stands at 24.75%.
• Its 3 year cash and equivalents growth rate is now at 277.65%.
• Its 2 year cash and equivalents growth rate is now at 245.56%.

Over the past 15 months, CDMO's revenue has gone up $29,667,000.

The table below shows CDMO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	125.535	11.373	122.932
2022-03-31	119.597	9.465	127.672
2021-12-31	115.977	26.713	9.775
2021-09-30	106.275	26.71	8.292
2021-06-30	101.23	26.513	5.612
2021-03-31	95.868	31.182	3.318

CDMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CDMO has a Quality Grade of C, ranking ahead of 27.37% of graded US stocks.
• CDMO's asset turnover comes in at 0.495 -- ranking 83rd of 682 Pharmaceutical Products stocks.
• COCP, HROW, and IBIO are the stocks whose asset turnover ratios are most correlated with CDMO.

The table below shows CDMO's key quality metrics over time.